These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6388831

  • 41. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
    Weick JK, Crowley J, Natale RB, Hom BL, Rivkin S, Coltman CA, Taylor SA, Livingston RB.
    J Clin Oncol; 1991 Jul; 9(7):1157-62. PubMed ID: 1646292
    [Abstract] [Full Text] [Related]

  • 42. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP, Lowitz BB, Haskell CM, Dorey FJ, Cline MJ.
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [Abstract] [Full Text] [Related]

  • 43. Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Bakowski MT, Crouch JC.
    Cancer Treat Rev; 1983 Sep; 10(3):159-72. PubMed ID: 6311415
    [No Abstract] [Full Text] [Related]

  • 44. Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lung.
    Saijo N, Shimizu E, Eguchi K, Shinkai T, Tominaga K, Shibuya M, Shimabukuro Z, Niitani H, Hoshi A.
    Cancer Treat Rep; 1983 Apr; 67(4):385-7. PubMed ID: 6189601
    [Abstract] [Full Text] [Related]

  • 45. Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C.
    Doyle LA, Ihde DC, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Puffenbarger R, Cordes RS, Minna JD.
    Am J Clin Oncol; 1984 Dec; 7(6):719-24. PubMed ID: 6442103
    [Abstract] [Full Text] [Related]

  • 46. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW, Palmer JB, Pratt MA, Clark RA.
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract] [Full Text] [Related]

  • 47. Carboplatin, vinblastine and mitomycin-C in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P, Athanassiades H, Psychogiou E, Kokolakis N, Giannioti E.
    J Chemother; 1992 Jun; 4(3):196-9. PubMed ID: 1325545
    [Abstract] [Full Text] [Related]

  • 48. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
    Shepard KV, Golomb HM, Bitran JD, Hoffman PC, Newman SB, DeMeester TR, Skosey C.
    Cancer; 1985 Nov 15; 56(10):2385-90. PubMed ID: 3876149
    [Abstract] [Full Text] [Related]

  • 49. Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
    Niell HB, Griffin JP, West WH, Neely CL.
    Cancer; 1984 Oct 01; 54(7):1260-3. PubMed ID: 6088022
    [Abstract] [Full Text] [Related]

  • 50. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
    Hoffman PC, Newman SB, Golomb HM, Demeester TR, Blough RR, Sovik CA.
    Eur J Cancer Clin Oncol; 1983 Jan 01; 19(1):33-8. PubMed ID: 6303793
    [Abstract] [Full Text] [Related]

  • 51. Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC Lung Cancer Working Party (Belgium).
    Klastersky J, Sculier JP, Dumont JP, Becquart D, Vandermoten G, Rocmans P, Michel J, Longeval E, Dalesio O.
    Cancer; 1985 Jul 01; 56(1):71-5. PubMed ID: 2988738
    [Abstract] [Full Text] [Related]

  • 52. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
    Dangubić V, Vukov N, Mrda V, Spasić D, Sikimić S, Popvić D, Perunović O, Bjelić R.
    Zb Vojnomed Akad; 1983 Jul 01; 25():40-4. PubMed ID: 6099941
    [No Abstract] [Full Text] [Related]

  • 53. Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    Chahinian AP, Green G, Holland JF.
    Am J Clin Oncol; 1984 Oct 01; 7(5):419-23. PubMed ID: 6439029
    [Abstract] [Full Text] [Related]

  • 54. [Preliminary results concerning the value of chemotherapy in the treatment of inoperable bronchial carcinoma (excluding small-cell anaplastic carcinoma)].
    Quoix E, Pelletier A, Schaller M, Pillement P, Dietemann-Molard A, Klein T, Spielmann P, Orion B, Chaix C.
    Rev Pneumol Clin; 1984 Oct 01; 40(2):127-9. PubMed ID: 6374840
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Selective bronchial arteriography and infusion chemotherapy in patients with bronchogenic carcinoma].
    Wu YM.
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Apr 01; 11(2):74-6, 126-7. PubMed ID: 3143488
    [No Abstract] [Full Text] [Related]

  • 60. Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
    Hoffman PC, Bitran JD, Golomb HM.
    Semin Oncol; 1983 Mar 01; 10(1):111-22. PubMed ID: 6301062
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.